The Sturge-Weber Syndrome treatment market demonstrates a stable and promising outlook, supported by the calculated growth to USD 194.70 million by 2025 and the ultimate projection of USD 260 million by 2030. The sustained CAGR of approximately 6% reflects the consistent demand for improved symptomatic management and the burgeoning potential of targeted therapies. As awareness and dia... https://www.databridgemarketresearch.com/reports/global-sturge-weber-syndrome-market